Ascendis Pharma Provides Update on Vision 3×3 Strategic Roadmap at 41st Annual J.P. Morgan…
– On track to fulfill all elements of Vision 3x3 to build a sustainable, profitable, leading biopharma company COPENHAGEN, Denmark, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided an update on its…